• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial

byPaary BalakumarandSimon Pan
January 9, 2026
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In patients with advanced cancer who are not hypoxemic, high-flow nasal therapy using room air and simple fan therapy provide safe, similar, and modest relief of dyspnea.

2. Because both treatments are safe, feasible, and equally effective, the choice of therapy should be guided by patient comfort, preference, and ease of use.

Evidence Rating Level: 2 (Good) 

Dyspnea is a common and distressing symptom in patients with advanced cancer, and while airflow-based therapies can provide relief, the comparative role of high-flow nasal therapy (HFNT) with room air versus simple fan therapy in nonhypoxemic patients remains uncertain. This prospective, randomized, controlled crossover trial evaluated the efficacy and feasibility of HFNT with air compared with fan therapy in relieving dyspnea among adults with incurable cancer and oxygen saturation ≥88%. Thirty-six patients with moderate dyspnea (numeric rating scale [NRS] ≥3) were enrolled, and 28 completed both interventions. Participants received 30 minutes of HFNT with room air and 30 minutes of fan therapy in randomized order, separated by a washout period. Both interventions resulted in statistically significant but modest reductions in dyspnea. Median dyspnea scores decreased from 5.0 to 3.5 with HFNT and from 5.0 to 2.5 with fan therapy. The median change in dyspnea was −1.0 NRS points for both treatments, with no significant difference between them. Over half of patients reported subjective dyspnea relief and good adaptation to each therapy. Adverse events were minimal, and no serious events occurred. The study concludes that HFNT with room air offers no advantage over fan therapy for dyspnea relief in nonhypoxemic patients with advanced cancer. Both modalities are feasible, safe, and provide mild symptom relief, supporting individualized, preference-based selection.

Click here to read this study in the Journal of Pain and Symptom Management

Image: PD

RELATED REPORTS

2 Minute Medicine Rewind January 5, 2026

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: dyspneahigh-flow nasal cannula (HFNC)oncologypalliative caresymptom management
Previous Post

The efficacy of preoperative evolocumab-rosuvastatin combination therapy in patients with ST-elevation myocardial infarction

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Weekly Rewinds

2 Minute Medicine Rewind January 5, 2026

January 5, 2026
Age and breast cancer risk factors associated with false-positive mammography results
Chronic Disease

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

December 29, 2025
Shorter overall survival among patients with monoclonal gammopathy of undetermined significance
Chronic Disease

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

December 24, 2025
2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen 

December 10, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial
  • The efficacy of preoperative evolocumab-rosuvastatin combination therapy in patients with ST-elevation myocardial infarction
  • Infrapatellar Fat Pad Glucocorticoid Injection in Knee Osteoarthritis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.